Cost of Viagra soars as hundreds of drug prices rise in US
Pfizer among those risking backlash with new year increases on many medicines
Pfizer has increased the price of Viagra by 39 per cent since the end of 2016
Drugmakers have imposed price rises of several times the rate of inflation on more than a thousand products in the US, a New Year move that risks a political backlash at a time of intense scrutiny on healthcare costs.
Pfizer, the largest standalone drugmaker in the US, raised the average wholesale price of 148 drugs by a mean average of 8.8 per cent, according to data seen by the Financial Times.
The list included several of its best-known medicines such as Viagra, the erectile dysfunction treatment, and Lyrica for nerve pain.
Other large drugmakers, including Allergan, GlaxoSmithKline, Gilead, Shire, Biogen, Teva, Baxter and Viiv also increased the US list prices of their medicines on January 1, according to the data.
For the most part, drugmakers held the increases at less than 10 per cent, but they still tracked well ahead of inflation, currently 2.2 per cent in the US.
Some pharmaceutical groups implemented much larger increases. Hikma, the London-listed drugmaker, raised the price of several strengths of morphine — which was first marketed in the 1800s — by between 75 and 90 per cent, taking a 25-pack of vials from $30 to $58.
Rx Savings Solutions, which makes software to help people lower the cost of prescription medicines, said it had recorded price increases on more than 1,300 products on the first day of the year.
“If GM raised the price of their trucks by four times the rate of inflation for multiple years, they wouldn’t sell any trucks,” said Michael Rea, chief executive of Rx Savings. “The inelastic market of pharmaceuticals continues to be stretched to new levels.”
The decision by pharmaceutical groups to raise the price of so many products is a gamble given the intense focus on drug costs in the US, the world’s largest and most profitable healthcare market.
The issue has been at the forefront of public debate since the presidential campaign, when Hillary Clinton targeted Martin Shkreli, the disgraced biotech entrepreneur, for raising an Aids and cancer medicine by 5,000 per cent.
President Donald Trump has also criticised the industry since winning election, accusing it of “getting away with murder” by charging high prices.
David Mitchell, a campaigner from Patients For Affordable Drugs, said it made little sense to focus only on “outliers” such as Shkreli given that successive years of above-inflation increases on thousands of common drugs were a bigger contributor to higher costs.
“The Shkrelis are emblematic of what’s going on across the whole system. When everyone applies these hikes across virtually every drug, it adds up to a hell of a lot more,” he said.


Cialis Tablets In Pakistan
ReplyDeleteCialis Gold 20 mg In Pakistan >> 03006668448
Cialis Black 200 mg In Islamabad >> 03006668448
Cialis Tablets 25 MG In Karachi >> 03006668448
Get Online Cialis Tablets In Lahore >> 03006668448
Viagra Tablets in Pakistan
ReplyDeleteViagra Tablets in Karachi
Viagra Tablets in Lahore